跳至主要内容
临床试验/NCT04499703
NCT04499703已完成不适用

Evaluation of the Retinal Health Monitoring System - Retinal Thickness Module in Subjects With Normal Macular Thickness and Subjects With Center-involving Macular Edema

Kubota Vision Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Evaluation of the RHMS-RTM retinal thickness measurements

研究概览

简要总结

Evaluate the ability and accuracy of the Retinal Health Monitoring System - Retinal Thickness Module (RHMS - RTM).

详细描述

Evaluation of the Retinal Health Monitoring System - Retinal Thickness Module in subjects with normal macular thickness and subjects with center-involving macular edema.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Corrected visual acuity (VA) of 20/125 or better, in the study eye(s)
  • Media clarity, undilated pupil size, and subject cooperation sufficient to obtain adequate OCT B-scans in the study eye(s)
  • Able to perform self-testing of retinal thickness with the RHMS-RTM after training
  • Able and willing to provide written informed consent before undergoing any study-related procedures
  • Group 1: Macula with normal thickness [central subfield thickness (CST): <305μm in women, and <320μm in men as measured by Heidelberg Spectralis SD-OCT in at least one eye. Patients diagnosed with dry AMD are eligible for enrollment into Group
  • No history of wAMD, DR, or RVO in either eye
  • Group 2 and Group 3, in at least one and the same eye: History of center-involving macular edema due to wAMD (Group 2); or DR or RVO (Group 3); Macular edema on SD-OCT with CST ≥305 μm in women, and ≥320μm in men as measured by Heidelberg Spectralis SD-OCT.

排除标准

  • History of corneal refractive surgery [e.g., laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), radial keratotomy (RK)] in the study eye(s)
  • History of epiretinal membrane, vitreomacular traction, or macular hole in the study eye(s)
  • Participation in any study using an investigational drug within 30 days of screening or an investigational device within 60 days of screening
  • Refractive error within defined limits
  • History of photocoagulation laser scar or other retinal scar in the central 3 mm of the macula, in the study eye(s)

结局指标

主要结局

Evaluation of the RHMS-RTM retinal thickness measurements

时间窗: 1 day

To evaluate the ability of the RHMS-RTM device to measure retinal thickness

次要结局

  • Repeatability of RHMS-RTM retina thickness measurements(1 day)
  • Intraretinal and subretinal fluid detection(1 day)
  • Comparison of retinal thickness measurements between the RHMS-RTM and the SD-OCT(1 day)

研究者

发起方
Kubota Vision Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验